| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.44 | 0.02 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.33 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.06 | 0.03 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |